Is LYMPHOPROLIFERATIVE DISORDER a side effect of PREDNISOLONE ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of PREDNISOLONE patients who developed LYMPHOPROLIFERATIVE DISORDER.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 280 individuals taking PREDNISOLONE reported LYMPHOPROLIFERATIVE DISORDER to the FDA. A total of 67432 PREDNISOLONE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between PREDNISOLONE and LYMPHOPROLIFERATIVE DISORDER. In doing so, we compare PREDNISOLONE with other drugs that cause LYMPHOPROLIFERATIVE DISORDER, to help you evaluate whether or not PREDNISOLONE causes LYMPHOPROLIFERATIVE DISORDER. Likewise, this page shows the most highly-reported side effects of PREDNISOLONE, so you can see if LYMPHOPROLIFERATIVE DISORDER ranks among PREDNISOLONE's most well-known side effects.

Summary Statistics
Reports of PREDNISOLONE causing LYMPHOPROLIFERATIVE DISORDER: 280
Reports of any side effect of PREDNISOLONE : 67432
Percentage of PREDNISOLONE patients where LYMPHOPROLIFERATIVE DISORDER is a reported side effect: 0.4152%

FDA reports of any drug causing LYMPHOPROLIFERATIVE DISORDER : 927
Average percentage for all medicated patients where LYMPHOPROLIFERATIVE DISORDER is reported as a complication: 0.0058%

Physician opinion on PREDNISOLONE as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing PREDNISOLONE:

RHEUMATOID ARTHRITIS ( 7311 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2961 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2112 patients )
RENAL TRANSPLANT ( 1220 patients )
IMMUNOSUPPRESSION ( 799 patients )
CROHN'S DISEASE ( 634 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 599 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 517 patients )
NON-HODGKIN'S LYMPHOMA ( 465 patients )
COLITIS ULCERATIVE ( 399 patients )
ASTHMA ( 378 patients )
B-CELL LYMPHOMA ( 369 patients )
MULTIPLE MYELOMA ( 357 patients )
PROSTATE CANCER ( 331 patients )
PROSTATE CANCER METASTATIC ( 312 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 281 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 275 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 259 patients )
INTERSTITIAL LUNG DISEASE ( 248 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 232 patients )
JUVENILE ARTHRITIS ( 224 patients )
PREMEDICATION ( 209 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 203 patients )
LUPUS NEPHRITIS ( 199 patients )
LYMPHOMA ( 184 patients )
NEPHROTIC SYNDROME ( 181 patients )
PROPHYLAXIS ( 181 patients )
POLYMYALGIA RHEUMATICA ( 163 patients )
HEART TRANSPLANT ( 156 patients )
GRAFT VERSUS HOST DISEASE ( 155 patients )
HODGKIN'S DISEASE ( 154 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 154 patients )
WEGENER'S GRANULOMATOSIS ( 153 patients )
LIVER TRANSPLANT ( 152 patients )
ARTHRITIS ( 152 patients )
PSORIATIC ARTHROPATHY ( 143 patients )
BURKITT'S LYMPHOMA ( 139 patients )
MYASTHENIA GRAVIS ( 121 patients )
LUNG TRANSPLANT ( 118 patients )
DERMATOMYOSITIS ( 102 patients )
BEHCET'S SYNDROME ( 99 patients )
TEMPORAL ARTERITIS ( 96 patients )
CHEMOTHERAPY ( 90 patients )
INFLAMMATION ( 90 patients )
MUSCULOSKELETAL PAIN ( 83 patients )
ILL-DEFINED DISORDER ( 82 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA ( 81 patients )
APLASTIC ANAEMIA ( 77 patients )
POLYARTHRITIS ( 77 patients )
AUTOIMMUNE HEPATITIS ( 74 patients )
VASCULITIS ( 71 patients )
PAIN ( 71 patients )
ADULT T-CELL LYMPHOMA/LEUKAEMIA ( 71 patients )
PEMPHIGUS ( 71 patients )
BRONCHITIS ( 69 patients )
ANTIINFLAMMATORY THERAPY ( 66 patients )
SARCOIDOSIS ( 65 patients )
ANKYLOSING SPONDYLITIS ( 64 patients )
BONE MARROW TRANSPLANT ( 61 patients )
PEMPHIGOID ( 60 patients )
STEM CELL TRANSPLANT ( 60 patients )
UVEITIS ( 60 patients )
ORGAN TRANSPLANT ( 59 patients )
CASTLEMAN'S DISEASE ( 56 patients )
ARTHRALGIA ( 56 patients )
PYODERMA GANGRENOSUM ( 56 patients )
STEROID THERAPY ( 55 patients )
POLYMYOSITIS ( 49 patients )
EVANS SYNDROME ( 47 patients )
MANTLE CELL LYMPHOMA ( 46 patients )
RASH ( 45 patients )
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS ( 45 patients )
MYELODYSPLASTIC SYNDROME ( 45 patients )
HENOCH-SCHONLEIN PURPURA ( 45 patients )
STILL'S DISEASE ADULT ONSET ( 44 patients )
LOWER RESPIRATORY TRACT INFECTION ( 44 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 44 patients )
DIARRHOEA ( 41 patients )
SCLERODERMA ( 41 patients )
COUGH ( 40 patients )
CORD BLOOD TRANSPLANT THERAPY ( 35 patients )
PNEUMONIA ( 35 patients )
DYSPNOEA ( 35 patients )
T-CELL LYMPHOMA ( 34 patients )
POSTOPERATIVE CARE ( 34 patients )
APLASIA PURE RED CELL ( 33 patients )
GLOMERULONEPHRITIS MEMBRANOUS ( 33 patients )
CHRONIC GRAFT VERSUS HOST DISEASE ( 32 patients )
ADRENAL INSUFFICIENCY ( 32 patients )
HYPERSENSITIVITY ( 32 patients )
ANAEMIA HAEMOLYTIC AUTOIMMUNE ( 31 patients )
MICROSCOPIC POLYANGIITIS ( 31 patients )
GLOMERULONEPHRITIS ( 31 patients )
DRUG EXPOSURE DURING PREGNANCY ( 29 patients )
MYALGIA ( 29 patients )
SINUSITIS ( 29 patients )
TRANSPLANT REJECTION ( 29 patients )
ECZEMA ( 28 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 28 patients )
IDIOPATHIC PULMONARY FIBROSIS ( 27 patients )
COLITIS ( 27 patients )
ROSACEA ( 27 patients )
PSORIASIS ( 26 patients )
SJOGREN'S SYNDROME ( 25 patients )
MULTIPLE SCLEROSIS ( 25 patients )
DUCHENNE MUSCULAR DYSTROPHY ( 24 patients )
NEPHRITIS ( 24 patients )
MYELOFIBROSIS ( 24 patients )
BRAIN OEDEMA ( 23 patients )
FOCAL SEGMENTAL GLOMERULOSCLEROSIS ( 22 patients )
HISTIOCYTOSIS HAEMATOPHAGIC ( 22 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 22 patients )
TRANSPLANT ( 22 patients )
OPTIC NEURITIS ( 21 patients )
SARCOMA ( 21 patients )
INFECTION ( 21 patients )
DERMATITIS ( 21 patients )
PYREXIA ( 20 patients )
NAUSEA ( 20 patients )
CHRONIC MYELOID LEUKAEMIA ( 20 patients )
B-CELL TYPE ACUTE LEUKAEMIA ( 20 patients )
PLASMACYTOMA ( 19 patients )
HEPATITIS ( 19 patients )
DRUG ERUPTION ( 19 patients )
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED ( 19 patients )
POLYARTERITIS NODOSA ( 18 patients )
INFLAMMATORY BOWEL DISEASE ( 18 patients )
RENAL VASCULITIS ( 18 patients )
EOSINOPHILIA ( 18 patients )
EPSTEIN-BARR VIRUS INFECTION ( 18 patients )
PUSTULAR PSORIASIS ( 17 patients )
COLLAGEN DISORDER ( 17 patients )
ACQUIRED HAEMOPHILIA ( 17 patients )
LUNG DISORDER ( 17 patients )
THROMBOCYTOPENIA ( 17 patients )
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS ( 16 patients )
URTICARIA ( 16 patients )
SERONEGATIVE ARTHRITIS ( 16 patients )
DERMATITIS ATOPIC ( 15 patients )
CONJUNCTIVITIS ( 15 patients )
RELAPSING-REMITTING MULTIPLE SCLEROSIS ( 15 patients )
VIITH NERVE PARALYSIS ( 15 patients )
RENAL AND PANCREAS TRANSPLANT ( 15 patients )
VOGT-KOYANAGI-HARADA SYNDROME ( 15 patients )
LANGERHANS' CELL HISTIOCYTOSIS ( 14 patients )
IGA NEPHROPATHY ( 14 patients )
LIVER DISORDER ( 14 patients )
ERYTHEMA MULTIFORME ( 14 patients )
PANCREAS TRANSPLANT ( 14 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 13 patients )
OBLITERATIVE BRONCHIOLITIS ( 13 patients )
HAEMANGIOMA ( 13 patients )
PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA ( 13 patients )
OSTEOARTHRITIS ( 13 patients )
NEPHROPATHY ( 13 patients )
TAKAYASU'S ARTERITIS ( 13 patients )
CHONDROCALCINOSIS PYROPHOSPHATE ( 13 patients )
NEUROPATHY PERIPHERAL ( 13 patients )
T-CELL TYPE ACUTE LEUKAEMIA ( 12 patients )
OEDEMA ( 12 patients )
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE ( 12 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 12 patients )
NON-HODGKIN'S LYMPHOMA STAGE IV ( 12 patients )
SYSTEMIC SCLEROSIS ( 12 patients )
HEART AND LUNG TRANSPLANT ( 12 patients )
PLASMABLASTIC LYMPHOMA ( 12 patients )
IMMUNE RECONSTITUTION SYNDROME ( 12 patients )
WHEEZING ( 12 patients )
AUTOIMMUNE DISORDER ( 12 patients )
HAEMOLYSIS ( 12 patients )
KIDNEY TRANSPLANT REJECTION ( 11 patients )
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ( 11 patients )
LYMPHOPROLIFERATIVE DISORDER ( 11 patients )
ANTIEMETIC SUPPORTIVE CARE ( 11 patients )
CONDITION AGGRAVATED ( 11 patients )
MALIGNANT LYMPHOID NEOPLASM ( 11 patients )
BRONCHOSPASM ( 11 patients )
PULMONARY FIBROSIS ( 11 patients )
METASTASES TO BONE ( 11 patients )
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ( 11 patients )
HERPES GESTATIONIS ( 10 patients )
LUPUS PNEUMONITIS ( 10 patients )
HYPEREOSINOPHILIC SYNDROME ( 10 patients )
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER ( 10 patients )
ORGANISING PNEUMONIA ( 10 patients )
IMMUNE SYSTEM DISORDER ( 10 patients )
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE ( 10 patients )
ADDISON'S DISEASE ( 10 patients )
RICHTER'S SYNDROME ( 10 patients )
AUTOIMMUNE THROMBOCYTOPENIA ( 10 patients )
ADRENOCORTICAL STEROID THERAPY ( 10 patients )
PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA ( 10 patients )
PROTEINURIA ( 10 patients )
LIVER TRANSPLANT REJECTION ( 10 patients )
PLATELET COUNT DECREASED ( 10 patients )
DECREASED APPETITE ( 10 patients )
GLOMERULONEPHRITIS PROLIFERATIVE ( 10 patients )
ARTHROPATHY ( 9 patients )
DERMATITIS EXFOLIATIVE ( 9 patients )
POLYCHONDRITIS ( 9 patients )
CUTANEOUS LUPUS ERYTHEMATOSUS ( 9 patients )
RESPIRATORY TRACT INFECTION ( 9 patients )
SCLERITIS ( 9 patients )
LEUKAEMIA ( 9 patients )
RENAL FAILURE CHRONIC ( 9 patients )
MYCOSIS FUNGOIDES ( 9 patients )
PNEUMOCYSTIS JIROVECI PNEUMONIA ( 9 patients )
BRONCHITIS CHRONIC ( 9 patients )
THROMBOCYTOPENIC PURPURA ( 9 patients )
GOUT ( 9 patients )

Drugs with high FDA adverse event association with LYMPHOPROLIFERATIVE DISORDER:

PREDNISOLONE (280 patients)
CYCLOSPORINE (209 patients)
GOLIMUMAB (203 patients)
METHOTREXATE (189 patients)
MYCOPHENOLATE MOFETIL (176 patients)
PREDNISONE (164 patients)
PROGRAF (163 patients)
CYCLOPHOSPHAMIDE (158 patients)
REMICADE (121 patients)
TACROLIMUS (113 patients)
AZATHIOPRINE (105 patients)
VINCRISTINE (98 patients)
DOXORUBICIN HCL (95 patients)
CAMPATH (95 patients)
PREDNISONE TAB (77 patients)
METHYLPREDNISOLONE (69 patients)
RITUXIMAB (58 patients)
FOSAMAX (50 patients)
THYMOGLOBULIN (49 patients)
CELLCEPT (43 patients)
ACYCLOVIR (42 patients)
SIMULECT (37 patients)
FLUDARA (36 patients)
OMEPRAZOLE (34 patients)
ACTEMRA (33 patients)
FLUCONAZOLE (31 patients)
PLACEBO (30 patients)
FLUDARABINE PHOSPHATE (30 patients)
FOLIC ACID (29 patients)
RHEUMATREX (28 patients)
AMOXICILLIN (27 patients)
LASIX (26 patients)
INFLIXIMAB (26 patients)
ENBREL (26 patients)
NEORAL (25 patients)
VORICONAZOLE (24 patients)
ASPIRIN (24 patients)
PREMARIN (23 patients)
MUCOSTA (23 patients)
GANCICLOVIR (23 patients)
ACETAMINOPHEN (22 patients)
LOXONIN (22 patients)
ETOPOSIDE (22 patients)
LORAZEPAM (22 patients)
PROCHLORPERAZINE (21 patients)
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (20 patients)
ATIVAN (20 patients)
PREVACID (20 patients)
MORPHINE SULFATE (19 patients)
ZOLPIDEM (19 patients)
ACTONEL (19 patients)
KETOCONAZOLE (19 patients)
RADIATION THERAPY (19 patients)
METHYLPREDNISOLONE SODIUM SUCCINATE (19 patients)
VINBLASTINE SULFATE (19 patients)
NEXIUM (19 patients)
CALCITRIOL (19 patients)
VITAMINS (UNSPECIFIED) (18 patients)
SOLU-MEDROL (18 patients)
IMATINIB MESYLATE (17 patients)
LANSOPRAZOLE (17 patients)
SULFASALAZINE (17 patients)
SYNTHROID (17 patients)
TEMAZEPAM (16 patients)
CELEBREX (16 patients)
ZOFRAN (16 patients)
CYTARABINE (16 patients)
LIDODERM (16 patients)
LIPITOR (16 patients)
BUSULFAN (16 patients)
NEUPOGEN (15 patients)
DIAZEPAM (15 patients)
IMURAN (15 patients)
ALLOPURINOL (15 patients)
IBUPROFEN (15 patients)
SIROLIMUS (15 patients)
COTRIM (15 patients)
ONCOVIN (15 patients)
DEXAMETHASONE (15 patients)
RAPAMUNE (15 patients)
ADRIAMYCIN PFS (14 patients)
NORVASC (14 patients)
ONDANSETRON (14 patients)
AMBIEN (14 patients)
DACARBAZINE (14 patients)
HYDROCORTISONE (14 patients)
RITUXAN (14 patients)
ZOVIRAX (14 patients)
RITUXIMAB (RITUXIMAB) (14 patients)
PLAQUENIL (14 patients)
ATGAM (13 patients)
MEROPENEM (13 patients)
FAMOTIDINE (13 patients)
BACTRIM (13 patients)
BENADRYL (13 patients)
CORTICOSTEROIDS (13 patients)
THIOGUANINE (13 patients)
HUMIRA (13 patients)
MERCAPTOPURINE (12 patients)
PREDONINE (12 patients)
OXYCODONE (12 patients)
ANTIHISTAMINES (12 patients)
MEDROL (12 patients)
MELPHALAN (12 patients)
LYRICA (12 patients)
COMPAZINE (11 patients)
LEVAQUIN (11 patients)
STEROIDS NOS (11 patients)
EFFEXOR (11 patients)
ZITHROMAX (11 patients)
ZOLOFT (11 patients)
GLEEVEC (11 patients)
SIMVASTATIN (11 patients)
AZULFIDINE (11 patients)
COLACE (11 patients)
LEVOTHYROXINE SODIUM (11 patients)
SUCRALFATE (11 patients)
NEULASTA (11 patients)
DOCUSATE SODIUM (10 patients)
ENALAPRIL MALEATE (10 patients)
FLUDARABINE (10 patients)
CILOXAN (10 patients)
ALEMTUZUMAB (10 patients)
OXYCONTIN (10 patients)
CYMBALTA (10 patients)
DESONIDE (10 patients)
PERCOCET (10 patients)
ENTEX PSE (10 patients)
ELIDEL (10 patients)
AMOXICILLIN AND CLAVULANATE POTASSIUM (10 patients)
VICODIN (10 patients)
PHENAZOPYRIDINE HCL TAB (10 patients)
RANITIDINE (10 patients)
PROMETHAZINE (10 patients)
DIOVAN HCT (10 patients)
MAGNESIUM HYDROXIDE TAB (10 patients)
VALCYTE (10 patients)
AUGMENTIN '125' (10 patients)
REGLAN (10 patients)
METRONIDAZOL ^ALPHARMA^ (10 patients)
SPIRIVA (10 patients)
NALOXONE (10 patients)
ZANAFLEX (10 patients)
OXYCODONE HCL AND ACETAMINOPHEN (10 patients)
PROTONIX (10 patients)
PROSCAR (10 patients)
DARVOCET-N 100 (10 patients)
DACLIZUMAB (9 patients)
TOCILIZUMAB (9 patients)
TAXOTERE (9 patients)
ALEVE (9 patients)
HORMONES (9 patients)
DURAGESIC-100 (9 patients)
MELATONIN (9 patients)
CEFOZOPRAN HYDROCHLORIDE (9 patients)
INFLUENZA VACCINE (9 patients)
VALACYCLOVIR HCL (9 patients)
LEVOFLOXACIN (9 patients)
MUCINEX (9 patients)
VALACICLOVIR (9 patients)
ANZEMET (9 patients)
ARA-C (9 patients)
ARTHROTEC (9 patients)
HUMIBID (9 patients)
ATENOLOL (9 patients)
HYDROMORPHONE HCL (9 patients)
ZOMETA (9 patients)
TRIPTORELIN (9 patients)
DEXRAZOXANE (9 patients)
IPRATROPIUM BROMIDE (9 patients)
PANTOPRAZOLE SODIUM (9 patients)
ROCALTROL (9 patients)
CIPROFLOXACIN (9 patients)
MS CONTIN (9 patients)
SENOKOT /USA/ (9 patients)
PIPERACILLIN W/TAZOBACTAM (9 patients)
SODIUM FLUORIDE (9 patients)
CASODEX (9 patients)
FLOMAX (9 patients)
TACROLIMUS (TACROLIMUS) (9 patients)
GLYCOLAX (9 patients)
DECADRON /NET/ (9 patients)
LUPRON (9 patients)
TAKEPRON (9 patients)
CARDURA /JOR/ (9 patients)
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (9 patients)
LISINOPRIL (8 patients)
CELECTOL (8 patients)
CELECOXIB (8 patients)
MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL) (8 patients)
ALFAROL (ALFACALCIDOL) (8 patients)
NYSTATIN (8 patients)
RECLAST (8 patients)
MAGNESIUM OXIDE (8 patients)
HYDROXYCHLOROQUINE SULFATE (8 patients)
RISEDRONATE SODIUM (8 patients)
CICLOSPORIN (8 patients)
MUCOSTA (REBAMIPIDE) (8 patients)
FOLIAMIN (8 patients)
NIFEDIPINE (8 patients)
ASPARA-CA (ASPARTATE CALCIUM) (8 patients)
TAMOXIFEN CITRATE (8 patients)
PEGFILGRASTIM (8 patients)
RIMATIL (8 patients)
LEVOTHROID (8 patients)
FOSAMAX PLUS D (8 patients)
BLEOMYCIN SULFATE (8 patients)
FUNGIZONE (8 patients)
FUROSEMIDE (8 patients)
BREDININ (8 patients)

Most common side effects for patients taking PREDNISOLONE:

PYREXIA (4557 patients)
PNEUMONIA (3820 patients)
SEPSIS (2455 patients)
ANAEMIA (2410 patients)
DIARRHOEA (2287 patients)
DYSPNOEA (2285 patients)
INTERSTITIAL LUNG DISEASE (2206 patients)
NAUSEA (2058 patients)
VOMITING (1865 patients)
RENAL IMPAIRMENT (1737 patients)
HEPATIC FUNCTION ABNORMAL (1682 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (1674 patients)
CYTOMEGALOVIRUS INFECTION (1674 patients)
RESPIRATORY FAILURE (1665 patients)
DRUG INEFFECTIVE (1658 patients)
RASH (1632 patients)
PLATELET COUNT DECREASED (1632 patients)
MALAISE (1575 patients)
BLOOD CREATININE INCREASED (1553 patients)
CONDITION AGGRAVATED (1498 patients)
HYPERTENSION (1481 patients)
ARTHRALGIA (1447 patients)
ALANINE AMINOTRANSFERASE INCREASED (1443 patients)
WHITE BLOOD CELL COUNT DECREASED (1433 patients)
HEADACHE (1427 patients)
C-REACTIVE PROTEIN INCREASED (1417 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (1402 patients)
DRUG INTERACTION (1386 patients)
LIVER DISORDER (1367 patients)
URINARY TRACT INFECTION (1352 patients)
PLEURAL EFFUSION (1292 patients)
PANCYTOPENIA (1283 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (1261 patients)
OEDEMA PERIPHERAL (1260 patients)
HERPES ZOSTER (1235 patients)
HAEMOGLOBIN DECREASED (1190 patients)
RENAL FAILURE ACUTE (1171 patients)
NEUTROPENIA (1161 patients)
MULTI-ORGAN FAILURE (1144 patients)
ABDOMINAL PAIN (1141 patients)
RENAL FAILURE (1129 patients)
THROMBOCYTOPENIA (1095 patients)
RHEUMATOID ARTHRITIS (1090 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (1081 patients)
INFECTION (1066 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (1055 patients)
HISTIOCYTOSIS HAEMATOPHAGIC (1027 patients)
CARDIAC FAILURE (1010 patients)
GASTROINTESTINAL HAEMORRHAGE (1004 patients)
DEHYDRATION (989 patients)
COUGH (958 patients)
DIZZINESS (953 patients)
DEATH (951 patients)
PAIN (948 patients)
FALL (941 patients)
DECREASED APPETITE (937 patients)
ASTHENIA (931 patients)
BACK PAIN (928 patients)
DIABETES MELLITUS (924 patients)
FATIGUE (913 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (894 patients)
HYPOTENSION (883 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (867 patients)
ATRIAL FIBRILLATION (836 patients)
SEPTIC SHOCK (818 patients)
MYOCARDIAL INFARCTION (808 patients)
CHEST PAIN (806 patients)
FEBRILE NEUTROPENIA (805 patients)
PULMONARY EMBOLISM (767 patients)
CONSTIPATION (762 patients)
ERYTHEMA (756 patients)
STAPHYLOCOCCAL INFECTION (751 patients)
CELLULITIS (750 patients)
WHITE BLOOD CELL COUNT INCREASED (743 patients)
WEIGHT DECREASED (737 patients)
CONVULSION (733 patients)
PAIN IN EXTREMITY (719 patients)
LEUKOPENIA (719 patients)
OSTEONECROSIS (671 patients)
PRURITUS (669 patients)
CEREBRAL INFARCTION (662 patients)
BRONCHITIS (659 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (651 patients)
CHILLS (647 patients)
DRUG EXPOSURE DURING PREGNANCY (633 patients)
BLOOD BILIRUBIN INCREASED (631 patients)
ASCITES (631 patients)
UPPER RESPIRATORY TRACT INFLAMMATION (629 patients)
STOMATITIS (620 patients)
ABDOMINAL PAIN UPPER (619 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (619 patients)
ASTHMA (602 patients)
BLOOD PRESSURE DECREASED (595 patients)
INFUSION RELATED REACTION (589 patients)
CONFUSIONAL STATE (580 patients)
IMPAIRED HEALING (571 patients)
TACHYCARDIA (559 patients)
MUSCULAR WEAKNESS (559 patients)
DISEASE PROGRESSION (554 patients)
DEEP VEIN THROMBOSIS (553 patients)
LOSS OF CONSCIOUSNESS (546 patients)
DEPRESSION (542 patients)
PULMONARY OEDEMA (540 patients)
CARDIAC ARREST (529 patients)
ASPERGILLOSIS (527 patients)
PERITONITIS (525 patients)
BLOOD UREA INCREASED (525 patients)
GAIT DISTURBANCE (522 patients)
GASTRIC ULCER (515 patients)
HEPATIC FAILURE (514 patients)
MYALGIA (514 patients)
BLOOD PRESSURE INCREASED (511 patients)
HYPOKALAEMIA (511 patients)
OEDEMA (508 patients)
MELAENA (501 patients)
JUVENILE ARTHRITIS (500 patients)
LYMPHADENOPATHY (498 patients)
LOWER RESPIRATORY TRACT INFECTION (498 patients)
HYPOAESTHESIA (497 patients)
WEIGHT INCREASED (493 patients)
NASOPHARYNGITIS (490 patients)
HYPONATRAEMIA (480 patients)
ANXIETY (477 patients)
PULMONARY FIBROSIS (459 patients)
KIDNEY TRANSPLANT REJECTION (447 patients)
RENAL DISORDER (444 patients)
JOINT SWELLING (443 patients)
LYMPHOCELE (442 patients)
TREMOR (442 patients)
INSOMNIA (441 patients)
ANOREXIA (440 patients)
HAEMODIALYSIS (437 patients)
TRANSPLANT REJECTION (437 patients)
HYPOXIA (437 patients)
NEUTROPHIL COUNT DECREASED (436 patients)
GASTROENTERITIS (436 patients)
LIVER FUNCTION TEST ABNORMAL (434 patients)
GRAFT VERSUS HOST DISEASE (433 patients)
SKIN ULCER (430 patients)
PULMONARY TUBERCULOSIS (425 patients)
OSTEOMYELITIS (424 patients)
PROTEINURIA (418 patients)
HAEMORRHAGE (415 patients)
HYPERGLYCAEMIA (410 patients)
PALPITATIONS (410 patients)
BONE MARROW FAILURE (408 patients)
DISEASE RECURRENCE (407 patients)
SOMNOLENCE (406 patients)
VASCULITIS (406 patients)
CEREBROVASCULAR ACCIDENT (404 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (404 patients)
PNEUMOTHORAX (401 patients)
CEREBRAL HAEMORRHAGE (398 patients)
ARRHYTHMIA (398 patients)
HYPERSENSITIVITY (397 patients)
LUNG DISORDER (396 patients)
JAUNDICE (396 patients)
SHOCK (396 patients)
AGRANULOCYTOSIS (390 patients)
PNEUMONIA ASPIRATION (386 patients)
OSTEOPOROSIS (386 patients)
BLOOD GLUCOSE INCREASED (379 patients)
LUNG INFILTRATION (372 patients)
CANDIDIASIS (372 patients)
NEPHROTIC SYNDROME (371 patients)
CARDIAC FAILURE CONGESTIVE (369 patients)
INFLAMMATION (369 patients)
HYPERKALAEMIA (367 patients)
LYMPHOMA (366 patients)
CYTOMEGALOVIRUS VIRAEMIA (365 patients)
IRON DEFICIENCY ANAEMIA (364 patients)
PARAESTHESIA (358 patients)
ARTHRITIS (358 patients)
BACTERIAL INFECTION (357 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (355 patients)
URTICARIA (355 patients)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (354 patients)
HAEMATURIA (353 patients)
INFLUENZA (352 patients)
CHOLELITHIASIS (349 patients)
CHEST DISCOMFORT (347 patients)
CHOLESTASIS (347 patients)
DYSPHAGIA (345 patients)
EPSTEIN-BARR VIRUS INFECTION (344 patients)
SYNCOPE (343 patients)
CROHN'S DISEASE (342 patients)
HEPATIC ENZYME INCREASED (335 patients)
CARDIO-RESPIRATORY ARREST (334 patients)
PERICARDIAL EFFUSION (333 patients)
HAEMATOMA (330 patients)
HEPATITIS (328 patients)
HEPATITIS B (328 patients)
TENDON RUPTURE (328 patients)
RESPIRATORY DISORDER (328 patients)
OXYGEN SATURATION DECREASED (327 patients)
MYELODYSPLASTIC SYNDROME (326 patients)
BLOOD ALBUMIN DECREASED (325 patients)
VISION BLURRED (324 patients)
DRUG ERUPTION (322 patients)
TOXIC EPIDERMAL NECROLYSIS (320 patients)
HYPOALBUMINAEMIA (318 patients)
PLEURISY (318 patients)
RHABDOMYOLYSIS (318 patients)
HALLUCINATION (317 patients)
STAPHYLOCOCCAL SEPSIS (316 patients)
PANCREATITIS ACUTE (316 patients)
TUBERCULOSIS (316 patients)
HAEMOPTYSIS (315 patients)
PSEUDOMONAS INFECTION (312 patients)
COLITIS ULCERATIVE (312 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for PREDNISOLONE

Issue	Description / Topic	Timestamp
QUESTION RENAL ARTERY OCCLUSION	how prednisolone cause occlusion effect	2015-03-25 11:12:23
QUESTION RENAL ARTERY OCCLUSION	how prednisolone can cause renal artery occlusion	2015-03-25 11:23:14
QUESTION ECHOCARDIOGRAM ABNORMAL	i had an echocardiogram to diagnose pericarditis whilst taking prednisolone for a bad chest infection. would this have affected the results of the echocardiogram	2015-05-28 00:53:56
QUESTION DRUG INTERACTION	Would prednisaline cause ankle swelling insimeone with AF. Taking bisoprolol?	2015-06-01 13:00:29
QUESTION DRUG INTERACTION	can I take methylprednisone,meclizine and diazepam together	2015-07-11 23:08:45
QUESTION ABORTION LATE	Yay! So glad for the clean news! I had to laugh at the whole comment about not sure if the hsitopal wanted the money for the scan or really needed to have it done. After so many procedures, I felt that way sometimes too! I know what clean scans do for us mentally too, so rest in this assurrance .not that we don't have plenty from the Lord, but you know what I mean. Now, speaking of cleaning, I need to get to my neglected house We were in Ohio for the weekend for Stacey's bridal shower, so I am using Jake's nap to try to get the house back into shape. Keep us updated. Always praying, love, Sara	2015-07-13 09:12:33
QUESTION HYPERTENSION	Does prednisone eye drops if used for one month cause elevation of blood pressure?	2015-10-21 06:13:27
QUESTION DUODENITIS	Can prednisole cause erosive duodenitis?	2015-11-20 17:09:22
QUESTION GUILLAIN-BARRE SYNDROME	CAN PREDNISOLONE EYE DROPS CAUSE GUILLAIN BARRE SYNDROME?	2015-11-24 12:48:49
QUESTION DRUG INTERACTION	WHAT ARE THE SIDE EFFECTS IF YOU ARE TAKING FOLIC ACID,GLIPIZIDE, LISINOPRIL, OMEPRAZOLE, ALONG WITH PREDNISONE	2016-01-08 13:45:05
QUESTION HAEMOGLOBIN INCREASED	I have MDS Does prednisolone make your count go up or down	2016-01-18 06:43:03
QUESTION DRUG INTERACTION	Can I take methylprednisolone and atripla together	2016-03-10 18:44:11
QUESTION PLATELET COUNT DECREASED	My diagnosis is essential thrombocythemia .Itake hydroy urea as a cytoredutive compound.Would taking prednisolone increase the reduction of platelets which I am trying to reduce to300ng/ml???	2016-03-21 17:46:20
QUESTION DRUG INTERACTION	I am taking somac,sodium valproate, and zoloft doctor has added prednisolone 25mg to these can this have caused my lower backache and severe headaches.	2016-05-04 08:33:40
QUESTION HYPERTENSION	Using for 2 months 4 times daily for dmek - papitationa and arthymia worse	2016-05-19 03:11:15
QUESTION DRUG INTERACTION	Predinsolone along with potassium bromide for dogs	2016-06-14 21:41:38
QUESTION PHOTOPHOBIA	MY MOM DID CATARACT SURGERY, NOW SHE USES MOXIFLOXIN + PREDLISOLONE EYE AND SHE FEELS LOT PHOTOPHOBIA REAONS	2017-05-19 07:45:33
QUESTION MALNUTRITION	could losing over 20%body weight while on high dose of prednisolone cause malnutrition, causing scaring of brain leading to complex partial siezures	2017-06-06 19:16:23

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about LYMPHOPROLIFERATIVE DISORDER and PREDNISOLONE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking PREDNISOLONE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in PREDNISOLONE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for PREDNISOLONE experts. If you are a healthcare provider experienced in prescribing PREDNISOLONE, please register here.